Immunohistochemical evaluation of E6/E7 HPV oncoproteins staining in cervical cancer

Anticancer Research

Volumn 36, Issue 6, 2016, Pages 3195-3198

  Stiasny, Annika ^a   Kuhn, Christina ^a   Mayr, Doris ^a   Alexiou, Christoph ^b   Janko, Christina ^b   Wiest, Irmi ^b   Jeschke, Udo ^a   Kost, Bernd ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Cervical cancer; E6; E7; HPV

Indexed keywords

DIAMINOBENZIDINE; POLYMER; PROTEIN E6; PROTEIN E7; DNA BINDING PROTEIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; ONCOPROTEIN;

CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INCUBATION TIME; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; STAINING; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VIROLOGY;

DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 84991694328     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Tota JE, Chevarie-Davis M, Richardson LA, Devries M and Franco EL: Epidemiology and burden of HPV infection and related diseases: Implications for prevention strategies. Prev Med 53(Suppl 1): S12-21, 2011.
2. Munoz N, Bosch FX, Castellsague X, Diaz M, de Sanjose S, Hammouda D, Shah KV and Meijer CJ: Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111(2): 278-285, 2004.
3. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC and Wacholder S: Human papillomavirus and cervical cancer. Lancet 370(9590): 890-907, 2007.
4. Assmann G and Sotlar K: HPV-associated squamous cell carcinogenesis. Pathologe 32(5): 391-398, 2011.
5. Wittekindt C, Wagner S, Mayer CS and Klussmann JP: Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer. GMS Curr Top Otorhinolaryngol Head Neck Surg 11: Doc09, 2012.
6. Wittekindt C, Wagner S, Mayer CS and Klussmann JP: Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer. Laryngorhinootologie 91(Suppl 1): S1-26, 2012.
7. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ and International Agency for Research on Cancer Multicenter Cervical Cancer Study G: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6): 518-527, 2003.
8. Gupta S, Takhar PP, Degenkolbe R, Koh CH, Zimmermann H, Yang CM, Guan Sim K, Hsu SI and Bernard HU: The human papillomavirus type 11 and 16 e6 proteins modulate the cellcycle regulator and transcription cofactor TRIP-BR1. Virology 317(1): 155-164, 2003.
9. Scheffner M, Huibregtse JM, Vierstra RD and Howley PM: The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75(3): 495-505, 1993.
10. Tang D, Wu D, Hirao A, Lahti JM, Liu L, Mazza B, Kidd VJ, Mak TW and Ingram AJ: ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J Biol Chem 277(15): 12710-12717, 2002.
11. Fehrmann F and Laimins LA: Human papillomaviruses: Targeting differentiating epithelial cells for malignant transformation. Oncogene 22(33): 5201-5207, 2003.
12. Kim KY, Wang DH, Campbell M, Huerta SB, Shevchenko B, Izumiya C and Izumiya Y: PRMT4-mediated arginine methylation negatively regulates retinoblastoma tumor suppressor protein and promotes e2f-1 dissociation. Mol Cell Biol, 2014.
13. Lipinski MM and Jacks T: The retinoblastoma gene family in differentiation and development. Oncogene 18(55): 7873-7882, 1999.
14. Jones DL and Munger K: Interactions of the human papillomavirus E7 protein with cell cycle regulators. Semin Cancer Biol 7(6): 327-337, 1996.
15. Boyer SN, Wazer DE and Band V: E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56(20): 4620-4624, 1996.
16. Yim EK and Park JS: The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer Res Treat 37(6): 319-324, 2005.
17. Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC and Nevins JR: Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci USA 89(10): 4549-4553, 1992.
18. Hoffmann M, Ihloff AS, Gorogh T, Weise JB, Fazel A, Krams M, Rittgen W, Schwarz E and Kahn T: P16(INK4A) overexpression predicts translational active human papillo-mavirus infection in tonsillar cancer. Int J Cancer 127(7): 1595-1602, 2010.
19. Preuss SF, Klussmann JP, Semrau R and Huebbers C: [update on HPV-induced oropharyngeal cancer]. HNO 59(10): 1031-1037, 2011.
20. Evans MF, Peng Z, Clark KM, Adamson CS, Ma XJ, Wu X, Wang H, Luo Y and Cooper K: HPV E6/E7 RNA in situ hybridization signal patterns as biomarkers of three-tier cervical intraepithelial neoplasia grade. PLoS One 9(3): e91142, 2014.
21. Hafner N, Gajda M, Altgassen C, Hertel H, Greinke C, Hillemanns P, Schneider A and Durst M: HPV16-e6 mrna is superior to cytokeratin 19 mRNA as a molecular marker for the detection of disseminated tumour cells in sentinel lymph nodes of patients with cervical cancer by quantitative reversetranscription pcr. Int J Cancer 120(9): 1842-1846, 2007.
22. Hoffmann M, Tribius S, Quabius ES, Henry H, Pfannenschmidt S, Burkhardt C, Gorogh T, Halec G, Hoffmann AS, Kahn T, Rocken C, Haag J, Waterboer T and Schmitt M: HPV DNA, E6i-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer-how valid is p16INK4A as surrogate marker? Cancer Lett 323(1): 88-96, 2012.
23. Bishop JA, Ma XJ, Wang H, Luo Y, Illei PB, Begum S, Taube JM, Koch WM and Westra WH: Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Am J Surg Pathol 36(12): 1874-1882, 2012.